We have developed a series of powerful and versatile conditional-replication, integration, and modular (CRIM) plasmids. CRIM plasmids can be replicated at medium or high copy numbers in different hosts for making gene (or mutant) libraries. They can be integrated in single copies into the chromosomes of Escherichia coli and related bacteria to study gene function under normal physiological conditions. They can be excised from the chromosome, e.g., to verify that phenotypes are caused by their presence. Furthermore, they can be retrieved singly or en masse for subsequent molecular analyses. CRIM plasmids are integrated into the chromosome by site-specific recombination at one of five different phage attachment sites. Integrants are selected as antibiotic-resistant transformations. Since CRIM plasmids encode different forms of resistance, several can be used together in the same cell for stable expression of complex metabolic or regulatory pathways from diverse sources. Following integration, integrants are stably maintained in the absence of antibiotic selection. Each CRIM plasmid has a polylinker or one of several promoters for ectopic expression of the inserted DNA. Their modular design allows easy construction of new variants with different combinations of features. We also report a series of easily curable, low-copy-number helper plasmids encoding all the requisite Int proteins alone or with the respective Xis protein. These helper plasmids facilitate integration, excision ("curing"), or retrieval of the CRIM plasmids.
Multicopy plasmids have greatly facilitated gene structurefunction studies. However, the use of such plasmids can lead to high-copy-number artifacts, especially in physiological studies. Thus, several methods have been developed for recombining genes on bacterial chromosomes in order to study their functions in single copies. Such methods are frequently used to construct novel Escherichia coli strains that stably express foreign genes for use in both basic research and biotechnology (5, 18, 27) . However, the development of strains encoding complex metabolic or regulatory pathways poses special problems that often require manipulating many genes and expressing them individually at different levels or under separate regulatory controls. To address these concerns, we have developed a series of plasmid-host systems for the introduction of multiple genes into the same cell in single copies. Our approach is based on genome targeting systems that utilize plasmids carrying a conditional-replication origin and a phage attachment (attP) site (17) . We refer to our plasmids as CRIM (conditionalreplication, integration, and modular) plasmids. CRIM plasmids can be integrated into or retrieved from their bacterial attachment (attB) site by supplying phage integrase (Int) without or with excisionase (Xis) in trans.
Advantages of our CRIM plasmid-host systems include the use of alternative attP and attB sites (for phages , HK022, 80, P21, and P22) and different selectable markers (for chloramphenicol, gentamicin, kanamycin, spectinomycin and streptomycin, tetracycline, and trimethoprim resistance) in conjunction with a polylinker or promoter (P araB , P rhaB , P rhaS , P tac , P syn1 , and P syn4 ) for ectopic expression of the cloned gene(s). These CRIM plasmids have the ␥ replication origin of R6K, which requires the trans-acting ⌸ protein (encoded by pir) for replication. So, they replicate at a medium (15 per cell) or high (250 per cell) plasmid copy number in pir ϩ or pir-116 (highcopy-number mutant) E. coli hosts (28) , respectively. Int helper plasmids are used for integration of CRIM plasmids into the corresponding chromosomal attB sites of normal (nonpir) hosts, which are nonpermissive for CRIM plasmid replication. Xis/Int helper plasmids are used for excision ("curing") of the respective CRIM plasmids from the chromosome, e.g., to verify that phenotypes are due to their presence. Xis/Int helper plasmids are also used for retrieval (cloning) of CRIM plasmids from the chromosome, e.g., to recover a particular CRIM plasmid after screening of CRIM plasmid or mutant libraries.
Since integration and retrieval involve phage-site-specific recombination events, the original and recovered plasmids are identical. CRIM plasmids can therefore be used for the construction of gene (or mutant) libraries that can be directly integrated into bacterial chromosomes in single copies for screening or selection purposes. Afterwards, CRIM plasmids can be retrieved from individual cells or en masse. The recovered plasmids can then be propagated as plasmids for molecular analysis or integrated directly into the chromosomes of other hosts for subsequent processing without further in vitro manipulation steps. We previously found similar oriR ␥ att plasmids to be extremely useful in mutagenesis studies, especially when it was important that the mutated gene be free of plasmid copy number effects (16) . We also found them to be useful in studying genes from diverse bacteria, including gram-negative and -positive cells (14, 15, 25, 34) . Our versatile CRIM plasmid-host systems should be widely useful in gene structure-function studies. Here we describe our basic set of CRIM plasmids, the requisite helper plasmids, and how to use them.
MATERIALS AND METHODS
Media and culture conditions. Luria-Bertani (LB) broth (without glucose), tryptone-yeast extract agar (pH 7.0), and glucose M63 agar were used as complex and minimal media (38) . SOB and SOC were prepared as described elsewhere (30) . To maintain plasmids, antibiotics (from Sigma, St. Louis, Mo.) were added as follows: ampicillin at 100 g/ml, chloramphenicol at 25 g/ml, gentamicin at 15 g/ml, kanamycin at 50 g/ml, spectinomycin and streptomycin (together) at 100 g/ml, trimethoprim at 300 g/ml, or tetracycline at 12.5 g/ml. Single-copy integrants were selected using chloramphenicol at 6 g/ml, gentamicin at 5 g/ml, kanamycin at 10 g/ml, spectinomycin and streptomycin (together) at 35 g/ml, trimethoprim at 25 g/ml, or tetracycline at 8 g/ml. We found that proper medium pH is especially important for selection of gentamicin-resistant (Gm r ) integrants. Complex media (tryptone-yeast extract agar) were used for selection of all forms of resistance except trimethoprim resistance, for which minimal media were used. Following primary selection, integrants were routinely maintained in the absence of antibiotics.
Bacteria. All strains are derivatives of E. coli K-12. Normal (self-replicating) plasmids were propagated in DH5␣ (12), BW5328, or BW25141. Strains from this laboratory are fully described Table 1 . The DE(araBAD)567 and DE(rhaBAD)568 mutations correspond to the ⌬araBAD AH33 and ⌬rhaBAD LD78 alleles (14) , respectively. The adjacent rrnB3 ⌬lacZ4787 mutations were previously called rrnB T14 ⌬lacZ WJ16 (14) . The ⌬endA9 allele corresponds to the ⌬endA8::tetAR mutation (from BT333 [9] ) after Flp-mediated excision of tetAR with pCP20 (9) . The recD1014 mutation originated from V355 (from G. C. Walker [33] ). The att P22(EcoB) allele refers to the att P22 site of E. coli B, which had been introduced into BW25368 (proA::Tn10) by using P1kc grown on NC3 (E. coli B/r hsdR, also called BW9688 [39] ) by selecting proline-independent transductants to make BW25676. Our standard wild-type E. coli K-12 strain is BD792 (36) , which is a direct F Ϫ descendant of W1485 (2) . The rph-1 allele refers to the rph frameshift mutation (19) , which is also present in E. coli BD792 (data not shown). Strain BD792, like both its parent, W1485, and wild-type E. coli K-12 EMG2 (20) , carries the rpoS396(Am) allele (data not shown). Several strains were therefore made rpoS ϩ . This was done in two steps. A strain was first made tetracycline resistant (Tc r ) and kanamycin resistant (Km r ) by using P1kc grown on ZK1001 (cysC95::Tn10 rpoS::kan; from R. Kolter). A resultant Cys Ϫ transductant was then made cysteine independent and kanamycin sensitive by using P1kc grown on MG1655. E. coli K-12 strains BW25113, BW25141, BW25142, and BW25695 are descendants of BD792 derivatives that were made rpoS ϩ . CRIM (oriR ␥ ) plasmids were propagated at a medium copy number in BW23473, BW24249, or BW25141 or at a high copy number in BW23474, BW24304, or BW25142. As standard wild-type hosts, we used BW25113 and BW25695 [like BW25113, except with att P22(EcoB) ]. CRIM plasmids were retrieved from integrants of BW24320 by using helper plasmid transformants of BW23473 (pir ϩ recA) or BW25141 (pir ϩ recA) when we used P1kc transduction (P1-Int-Xis [PIX] cloning [16] ) or helper plasmid transformants of BW23838 (pir ϩ recD) when we used transformation (see below). Strain BW37 was used as the recipient for selection of Ilv ϩ transductants when we determined the Ilv ϩ transducing titers of P1kc lysates. Molecular biology methods. PCR fragments for cloning were generated by using Vent (New England Biolabs, Beverly, Mass.) or Pfu DNA polymerase (Stratagene, La Jolla, Calif.) and oligonucleotide primers (from IDT Inc., Coralville, Iowa). Other enzymes were from New England Biolabs or Promega (Madison, Wis.). Qiagen (Hilden, Germany) products were used for the isolation of plasmid DNA, extraction of DNA fragments from agarose gels, and purification of PCR fragments.
Plasmids. CRIM ( Fig. 1 ) and CRIM helper plasmids ( Fig. 2 ; Table 2 ) were assembled by standard techniques. pLA2 was constructed by L. Avramova and Wanner (unpublished) . Various fragments were subcloned directly or cloned as PCR-generated fragments containing restriction site extensions (Table  3 ). The bla, cat, kan, tet, and oriR ␥ segments were from pANTS␥, pCANTS␥, pKANTS␥, and pTANTS␥ (32) (from M. Koob); the att (with a destroyed NdeI site) and lacI q -P tac segments were from pCANTS␥⌬NdeI and pCANTS␥lacI q SLP (26) (both from A. S. Lynch); the lacZ cassette in pAH125 was from pCS3 (29) ; the promoterless uidAf (the uidA2 fusion in pSK49⌬::uidA2) cassette was from pWM3 (29) ; the P araB fragment in pAH150 was from pAH31 (14) ; and P rhaB in pAH120 was from pLD78 (14) . The lacZ gene in pLA2 was constructed in a series of steps that involved introducing an NdeI site overlapping its Met start codon and eliminating a native NdeI site; the lacZ gene was generated using pOD (31) as the template, so it has a mutated lacO2 region; and the P araB fragment in pLA2 was generated as a PCR fragment (Table 3) . Our initial CRIM plasmid pAH55 is a derivative of pKANTS␥ in which we introduced a mutated att segment (lacking its native NdeI site), lacI q , and uidAf segments in sequential steps. The CRIM helper plasmids were assembled using pINT-ts (17) as the backbone. PCR fragments were generated by using as templates pHH7013 and pHH7009 (from J. C. Hu) for P syn1 and P syn4 ; a derivative of pLD78 (14) called pLD81 (from L. Daniels) for P rhaS ; p34E-Tp (11) (from D. E. Woods) for dhfr; pBBR1MCS-5 (22) (from M. Kovach) for gen; (from R. Somerville) for xis ; pBAD33 (13) (from L.-M. Guzman) and pBS1att P6-1 (6) (from A. Campbell) for att P21 , xis P21 , and int P21 ; pEY109 (42) (from E. Yagil) for att HK022 , xis HK022 , and int HK022 ; pJL10 and pJL110 (23) (from A. Landy) for att 80 , xis 80 , int 80 , and att P22 ; and P22 (from S. Maloy) for xis P22 and int P22 .
CRIM plasmid integration. Cells carrying a CRIM helper plasmid were grown in 5 ml of SOB cultures with ampicillin at 30°C to an optical density of 600 nm of ca. 0.6 and then made electrocompetent. Following electroporation, cells were suspended in SOC without ampicillin, incubated at 37°C for 1 h and at 42°C for 30 min, and then spread onto selective agar and incubated at 37°C. Colonies were purified once nonselectively and then tested for antibiotic resistance for stable integration and loss of the helper plasmid and by PCR for copy number (see below).
CRIM plasmid excision. Cells were transformed with the respective Xis/Int CRIM helper plasmid and then spread on ampicillin agar media at 30°C. Colonies were purified once or twice nonselectively on plates that were incubated for 1 h at 42°C and overnight at 37°C. They were then tested for antibiotic sensitivities and by PCR for loss of the integrated plasmid.
CRIM plasmid retrieval. P1kc lysates were made on integrants by using standard procedures. Recipient cells carrying the corresponding Xis/Int CRIM helper plasmid were grown in LB agar with ampicillin at 30°C to early stationary phase and then infected with a P1kc lysate. Following phage absorption, centrifugation, and resuspension as described elsewhere (38) , the infected cells were incubated for 1 h at 37°C, 30 min at 42°C, and an additional hour at 37°C and then spread onto selective media (without ampicillin) for the CRIM plasmid and incubated at 37°C. To recover plasmids by transformation, chromosomal DNAs were isolated from integrants and subjected to shearing by sonication or DNase I digestion in the presence of divalent manganese (1) . Recipient cells carrying a helper plasmid were grown in 5-ml SOB cultures with ampicillin at 30°C to an optical density at 600 nm of ca. 0.6 and then made electrocompetent. Following electroporation, cells were suspended in SOC without ampicillin, incubated at 37°C for 1 h and at 42°C for 30 min, and then spread onto selective agar and incubated at 37°C.
PCR verification of integrant copy number. Isolated colonies were picked up with a plastic tip and suspended in 20 l of water. Five microliters of the cell suspension, 10 pmol of each primer (P1 to P4 together), and 0.5 U of Taq DNA polymerase (New England Biolabs) were combined in 1ϫ PCR buffer-2.5 mM MgCl 2 with deoxynucleoside triphosphates in a final volume of 25 l. PCR was carried out for 25 cycles with denaturing for 1 min at 94°C, annealing for 1 min (Table 4) , and extension for 1 min at 72°C.
DNA sequencing. The DNA sequences of all CRIM and CRIM helper plasmids were deduced in their entirety by verifying the sequences of all modules used in their constructions. PCR-amplified segments were verified by automated DNA sequencing of both strands after initial cloning. Many were initially cloned into SmaI-digested pSPORT1 (from Gibco BRL, Gaithersburg, Md.) or EcoRIand NcoI-digested pLITMUS29 (from New England Biolabs). Others were cloned directly into a CRIM plasmid and then sequenced. Several additional regions were also sequenced to permit generation of detailed maps of all CRIM and CRIM helper plasmids.
FIG. 2. CRIM helper plasmid.
All helper plasmids express int alone or with xis from p R under cI857 control, which is also borne by these plasmids, and are temperature sensitive for plasmid replication. As described in Materials and Methods, all are derivatives of pINT-ts, whose complete DNA sequence we determined in this study. With one exception, the xis-int plasmids express these genes in the same orientation as that found naturally. The construction of pAH129 resulted in placing xis 80 upstream of int 80 to create an xis-int 80 operon (data not shown). We also deliberately destroyed the native BamHI site in int during the construction of pAH57 by introducing a silent mutation with the xis -5Ј primer (Table 2) . Pr, phage promoter.
FIG. 1.
Structures of CRIM plasmid series. Gene designations include aadA (aminoglycoside adenyltransferase for spectinomycin and streptomycin resistance), bla (␤-lactamase for ampicillin resistance), cat (chloramphenicol acetyltransferase), dhfr (dihydrofolate reductase for trimethoprim resistance), gen (gentamicin-3-acetyltransferase for gentamicin resistance), kan (aminoglycoside 3Ј-phosphotransferase for kanamycin resistance), pstS‫ء‬ (a mutant pstS, P i -specific binding protein), tetA (tetracycline resistance), and uidAf (the uidA2 fusion in pSK49⌬::uidA2 [16] ). The multiple cloning site (MCS) is from pUC18 (44) . Unique sites within the MCS of pAH68 include, from left to right, SphI, PstI, SalI, XbaI, BamHI, SmaI, KpnI, SacI, and EcoRI. All sites are illustrated for the enzymes shown. Sites destroyed during construction are marked with an asterisk. Modules are flanked by SphI, EcoRI (BamHI or NdeI), NheI, NcoI, NotI, and ClaI (and/or BsaI) sites. Plasmids with aadA, bla, or gen facilitate certain constructions as they have a unique NcoI site. Due to the manner in which these plasmids were constructed, the P araB region of pAH150, but not of pLA2, encodes an N-terminal portion of AraC as a fusion protein. As a consequence, P araB is expressed at a normal level in pLA2 but at a much reduced level in pAH150 (see the text). All attP sites were designed taking into account information on important DNA binding sites and structure (23, 35, 43) . Accordingly, the att P21 sequence encodes the C terminus of icd and the att P22 sequence includes sequences for the thrW tRNA gene (6) . Unexpectedly, we found that CRIM plasmids carrying att P22 s or att 80 s (Table 3) failed to integrate or gave very few integrants, respectively, suggesting that additional att sequences are required (data not shown). Plasmids carrying a longer att 80 site (such as pAH153 and pAH162) integrated efficiently, while those carrying the longer att P22 site (such as pAH154) integrated less frequently than others (see the text). Primers routinely used to verify cloned inserts by PCR or DNA sequencing include rgnB-f (TTGTCGGTGAACGCTCTCCT), ParaB-f (CACATTGATTATTTGCACGG), PrhaB-f (CGTTCATCTTTCCCTGGT), and tL3-r (AGGATGCGTCATCGCCATTA). Priming sites rgnB-f and tL3 are common to all CRIM plasmids and are useful for sequencing inserts in all CRIM plasmids, except those containing lacI q , in which only tL3-r remains useful.
Nucleotide sequence accession numbers. GenBank accession numbers for the CRIM plasmids are AY048713 (pAH55), AY048714 (pAH56), AY048716 (pAH63), AY048717 (pAH68), AY048719 (pAH70), AY048720 (pAH81), AY048722 (pAH95), AY048723 (pAH120), AY054372 (pAH125), AY048730 (pAH143), AY048731 (pAH144), AY048732 (pAH145), AY048733 (pAH150), AY048734 (pAH152), AY048735 (pAH153), AY048736 (pAH154), AY048737 (pAH156), AY048738 (pAH162), AY048739 (pCAH56), AY048740 (pCAH63), and AY054373 (pLA2). GenBank accession numbers for the CRIM helper plasmids are AY048715 (pAH57), AY048718 (pAH69), AY048720 (pAH83), AY048724 (pAH121), AY048725 (pAH122), AY048726 (pAH123), AY048727 (pAH129), AY048728 (pAH130), AY048729 (pAH131), and AY048741 (pINTts).
RESULTS AND DISCUSSION
General description. Our basic CRIM plasmids are shown in Fig. 1 . Each has four general regions in common: a polylinker or a cloning region consisting of a promoter for ectopic expression with or without a regulatory gene, a phage attachment (attP) site, a conditional-replication origin (oriR ␥ ), and a selectable marker. Several already contain an E. coli gene (lacZ, phoB, phoR, pstS, or uidAf) within the cloning region; however, these genes act solely as replaceable ("stuffer") fragments in new constructions. In addition, all CRIM plasmids have bacterial (rgnB) and phage (t0, tL3) terminators flanking their cloning region to protect other segments from transcriptional readthrough. The CRIM plasmids were designed so that stan- dard cloning methods can be used for making new ones with various combinations of these and other features, as necessary. CRIM plasmid integration. CRIM plasmids can be simply integrated into the chromosome by direct transformation of normal (non-pir) hosts carrying a CRIM helper plasmid synthesizing the respective Int ( Fig. 2; Table 2 ). Int synthesis from the helper plasmids is induced at elevated temperatures. Since the helper plasmids are also temperature sensitive for replication (see Materials and Methods), the resulting transformants are nearly always simultaneously cured of the helper plasmid. Upon integration at the respective attB site, all CRIM plasmids lie in the same relative orientation on the E. coli chromosome (Fig. 3) . Therefore, even though they have sequences in common (tL3, oriR ␥ , and rgnB), homologous recombination among them does not lead to instability because essential chromosomal genes lie between these attB sites. Due to the high efficiency of site-specific recombination, these homologies also do not interfere with integrating multiple CRIM plasmids at different attB sites in the same strain.
To test for single-copy integration, we routinely use a single PCR with four primers (P1, P2, P3, and P4 in Fig. 4A ; see Materials and Methods). Single-copy integrants are revealed as integrants that have lost the fragment corresponding to the respective attB site (the P1 to P4 fragment) and simultaneously gained two new fragments that are characteristic of the attL (BOPЈ; the P1-to-P2 fragment) and attR (POBЈ; the P3-to-P4 fragment) junctions. Recombinants with two (or more) CRIM plasmids at the attB site are also easily distinguishable. Such multiple integrants also gain a third fragment characteristic of the attP site of the integrating plasmid (the P2-to-P3 fragment). Recombinants resulting from integration elsewhere on the chromosome yield instead PCR products for both the attB (the P1-to-P4 fragment) and attP (the P2-to-P3 fragment) sites, provided that such integration occurs via homologous recombination or otherwise outside the attP region. Based on these criteria, we have shown that integration occurs primarily at the respective attB site and always requires the corresponding Int. The most common undesirable events are the occurrence of multiple-copy integrants; however, these integrants seldom represent more than a few percentages of the antibiotic-resistant transformants. With one exception, this is true for all CRIM plasmids (data not shown).
The exception concerns the att P22 CRIM plasmids. These plasmids differ in two ways. First, the att P22 plasmids integrate ca. 100-fold less efficiently than the others. Second, one-half or more of the resulting att P22 plasmid integrants are often incorrect and appear to occur via recombination events that do not involve the att P22 site. Since wild-type E. coli K-12 apparently has an uncharacterized prophage occupying the chromosomal att P22 site (unpublished results), we considered the possibility that this prophage interferes with site-specific integration at this site. However, we obtained similar results with an otherwise isogenic host lacking this prophage, suggesting that an additional factor or sequence is required for efficient att P22 recombination. Nevertheless, att P22 CRIM plasmids have still been quite useful for constructing strains that have multiple FIG. 3 . Locations of chromosomal attB sites. Wild-type E. coli K-12 contains the prophage element e14 adjacent (clockwise) to att P21 (6) . Sites are based on the linkage map (3) and the positions of the appropriate attB core sequences (for att , gCTTttTtatActAA; for att HK022 , CTTTaggtgaa; for att P21 , tGCtGCgcCATAT; for att P22 , ATTcgtAATGcGAAG; for att 80 , AACAcTTTcttAAAt; lowercase letters indicate bases that differ from the consensus [6] ), in the E. coli K-12 genome sequence (4) . E. coli K-12 has two att P22 sites separated by ca. 34 kb (at nucleotides 262125 and 296433 of the genome), which is consistent with their being separated by an uncharacterized phage. Furthermore, by using PCR and P22(EcoB) primers (Table 2) , we have shown that the intervening sequences is absent from E. coli B, so it lacks this phage (data not shown). a Primers P2 (ACTTAACGGCTGACATGG) and P3 (ACGAGTATCGAGATGGCA) are the same for all attP sites. "Temp" is the annealing temperature. The P4 priming sites for att P21 and att P22 lie within prophage elements of wild-type E. coli K-12 (Fig. 2 ). An att P21 CRIM plasmid integrates to the left (counterclockwise) of e14. The e14attR primers were used to test for integration to the right (clockwise) of e14. E. coli K-12, but not E. coli B, has an uncharacterized prophage in att P22 . An att P22 CRIM plasmid integrates adjacent (counterclockwise) to this prophage in E. coli K-12. Primers for att P22(EcoB) were used to test for integration of att P22 CRIM plasmids in E. coli K-12 strains (BW25695 and others) with an "empty" att P22 site from E. coli B.
b Sizes are in nucleotides.
FIG. 4. Integration (A), excision (B)
, and retrieval (C) of CRIM plasmids from att HK022 . POPЈ and BOBЈ are sites for phage site-specific recombination according to the Campbell model (7, 41) . P1, P2, P3, and P4 are priming sites used in PCR tests (see Materials and Methods).
CRIM plasmids. In these cases, we have usually integrated att P22 CRIM plasmids before integrating others to prevent the att P22 plasmid from recombining with others via homologous recombination, which can also occur at low frequency. The att P22 CRIM plasmids are therefore less valuable as vectors for library construction or other uses requiring high integration efficiency.
CRIM plasmid excision. Integrated CRIM plasmids can also be excised very efficiently. CRIM plasmid excision is carried out by using CRIM helper plasmids encoding both Xis and Int (Fig. 4B) . We found that all CRIM plasmids were easily eliminated from a specific attP site when using the respective Xis/ Int helper plasmid but not when using an Xis/Int helper plasmid for a different attP site. In most cases, 100% of the transformants were cured of the respective CRIM plasmid after a single colony purification step (see Materials and Methods). No aberrant (nonspecific) excision events were detected when we used cells containing multiple CRIM plasmids integrated at different sites (data not shown). We have used excision as a simple way to verify that novel phenotypes result from the presence of particular CRIM plasmids. We have also found excision to be useful in certain strain constructions. For example, when studying complex metabolic or regulatory pathways, it has often been necessary to make strains containing multiple CRIM plasmids in various combinations. In such cases, it has occasionally been more convenient to excise a single CRIM plasmid from a strain containing a combination of different CRIM plasmids in order to introduce an alternative one than to construct an entirely new strain containing most of the same CRIM plasmids by integrating each individually.
CRIM plasmid retrieval. The ease of retrieving CRIM plasmids from the chromosome is an especially valuable attribute. Because Xis and Int catalyze the excision and circularization of molecules from the corresponding att sites, CRIM plasmids can be retrieved simply by introducing chromosomal DNAs from an integrant into permissive (pir ϩ ) hosts that synthesize Xis and Int from a helper plasmid. We have usually done this by using the generalized transducing phage P1kc in a process that we have called PIX cloning (Fig. 4C) (16) .
PIX cloning is done using recipients that are pir ϩ for replication of the CRIM plasmids and recA to avoid homologousrecombination events and carry the appropriate Xis/Int CRIM helper plasmid. We measured PIX cloning efficiencies by determining the number of antibiotic-resistant transductants per infectious phage in standard phage P1 crosses (Table 5) . We assayed the transducing titer of the same P1kc lysates by determining the number of Ilv ϩ transductants. As shown in Table  5 , PIX cloning is an extremely efficient process. Efficient retrieval occurs only in the presence of the proper CRIM helper plasmid (data not shown). The recovered plasmids have always been correct, based on restriction enzyme analysis of plasmid DNAs isolated from several representative transductants in numerous such crosses. We have also used PIX cloning to recover plasmids for direct DNA sequence analysis (16; unpublished results). In addition, we have shown that CRIM plasmids can be recovered following transformation of a recD pir ϩ host carrying the appropriate helper plasmids with chromosomal DNA (Materials and Methods). Accordingly, CRIM plasmids are also retrievable from bacteria that are insensitive to phage P1kc.
Using CRIM plasmids. Although CRIM plasmids can be used with most ordinary (non-pir) E. coli strains, we have made standard hosts for their use. These hosts have defined deletions of araBAD, rhaBAD, and lacZ and are lacI q . Hence, they cannot catabolize arabinose or rhamnose and yet encode the regulatory proteins (AraC, RhaR, and RhaS) required for ectopic expression of foreign genes from the corresponding promoters (P araB , P rhaB , and P rhaS , also called P BAD or araBp, PrhaB, and PrhaS, respectively). These hosts provide tight regulation of these and LacI-controlled promoters. They can also be used with lacZ fusions generated using our standard CRIM lacZ transcriptional fusion vector pAH125 (Fig. 5) . Expression levels of P araB in pLA2, P rhaB in pAH120, and P rhaS in pAH152 were similar to those reported elsewhere (14) . We have also shown elsewhere that P rhaB is an especially tightly regulated promoter (14) . The synthetic (P syn1 and P syn4 ) promoters provide for low-level unregulated gene expression. These promoters are juxtaposed to a ribosome binding site and AUG start codon that is contained within an NdeI site for convenient construction purposes. With the exception of plasmids carrying att P21 , the NdeI site is unique (14) .
Unexpectedly, we have recently found that P araB expression is much lower in pAH150 than in pLA2, which shows a normal level of expression (14; L. Avramova and B. L. Wanner, unpublished). Lower expression in pAH150 results from interference by an N-terminal AraCЈ fusion protein that is encoded by the P araB segment in pAH150 but not in pLA2. Nevertheless, both of these P araB CRIM plasmids have been useful as they both show arabinose-regulated promoter expression. pAH150 has been especially useful for conditional expression of regulatory genes, such as phoB, requiring low-level expression, while pLA2 has been more useful for expression of structural genes requiring high-level expression. Elsewhere, we have recently described E. coli hosts that show homogeneous expression of genes under P araB control which constitutively synthesize the low-affinity AraE transporter from the chromosome (21) .
We have also shown that att P22 and att CRIM plasmids integrate into the appropriate attB sites of Salmonella enterica serovar Typhimurium. Others were not tested. Since phages tend to exploit highly conserved and sometimes essential genes (e.g., tRNA genes) as sites for integration (8) , several CRIM plasmids can probably integrate into chromosomes of other bacteria, especially in other members of the family Enterobacteriaceae and related families. CRIM plasmids should therefore be useful in many applications involving bacteria other than common laboratory strains. 
